Mentice AB (publ) (STO:MNTC)

Market Cap	364.23M -42.3%
Revenue (ttm)	275.97M -0.0%
Net Income	-43.31M
EPS	-1.57
Shares Out	28.13M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,956
Average Volume	5,686
Open	13.00
Previous Close	12.95
Day's Range	13.00 - 13.70
52-Week Range	8.50 - 26.60
Beta	0.33
RSI	49.84
Earnings Date	Feb 2, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patie...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 128
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.